Megan Sniecinski serves as Executive at BIOCRYST PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Megan Sniecinski has executed 5 insider transactions totaling $65.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 12, 2026 involved selling 885 shares valued at $244.0K.
Megan Sniecinski currently holds 28,530 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Megan Sniecinski has been a net buyer of BCRX stock. They have purchased $65.3K and sold $0 worth of shares.
Megan Sniecinski's most recent insider trade was on Jan 12, 2026, when they sold 885 shares at $275.74 per share.
Get notified when new Form 4 filings are submitted
| $288.45 |
| Discretionary |
| Jan 8, 2026 | PRAX | $0 | Award | 7,700 | $N/A | Discretionary |
| Jan 8, 2026 | PRAX | $0 | Award | 9,625 | $N/A | Discretionary |
| Nov 18, 2019 | BCRX | $65.3K | Purchase | 45,000 | $1.45 | Discretionary |